NCT05087641View on ClinicalTrials.gov

A Multicenter, Prospective Trial of the IAB in Adults Suffering From COPD/Emphysema

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 3, 2022

Primary Completion Date

March 27, 2024

Study Completion Date

January 31, 2027

Conditions
EmphysemaPulmonary Disease, Chronic Obstructive
Interventions
DEVICE

IAB System

Bronchoscopic implantation of one or multiple IABs

Trial Locations (3)

CEP 90035-003

Hospital de Clinicas de Porto Alegre, Porto Alegre

D-69126

Thoraxklinik, University of Heidelberg, Heidelberg

9713 GZ

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

Pulmair Medical, Inc.

INDUSTRY